Advancing Cancer Treatment: Enhanced Combination Therapy through Functionalized Porous Nanoparticles.

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Cancer poses a significant global health challenge, driving the need for advanced therapeutic strategies.
• Conventional cancer treatments often face limitations such as poor efficacy and severe side effects.
• Combination therapy, integrating multiple treatment modalities, shows potential to overcome these limitations.

Purpose of the Study:

• To review the functionalization of porous nanoparticles for advanced cancer combination therapy.
• To highlight the role of various porous nanomaterials in improving therapeutic outcomes.
• To discuss synthesis, functionalization, and application of these nanoparticles in cancer treatment.

Main Methods:

• Review of literature on porous nanoparticles including mesoporous silica nanoparticles (MSN), nanoparticles coated with mesoporous silica (NP@MS), metal-organic frameworks (MOF), mesoporous platinum nanoparticles (mesoPt), and carbon dots (CDs).
• Focus on functionalization strategies using ligands, biomaterials, and polymers.
• Analysis of nanoparticle applications in drug solubility, bioavailability, targeted delivery, and controlled release.

Main Results:

• Porous nanoparticles demonstrate enhanced drug solubility, bioavailability, and targeted delivery capabilities.
• Functionalized nanoparticles facilitate co-delivery of multiple therapeutic agents (e.g., drugs, photosensitizers).
• Stimuli-responsive properties enable controlled drug release for improved combination therapy efficacy.

Conclusions:

• Functionalized porous nanoparticles represent a powerful platform for developing effective cancer combination therapies.
• These nanomaterials offer versatile solutions for overcoming challenges in drug delivery and treatment efficacy.
• Further research into synthesis and functionalization will advance their clinical application in oncology.